Clinical Trials Browser

Phase 1/2 × Uveal Melanoma × montanide ISA 51 × Clear all

NCT00089219 2014-11-20

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma